| AAVS1 |
|
adeno-associated virus integration site 1
|
|
|
0.595 |
0.731 |
| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| CCT |
|
cataract, congenital, total
|
|
|
0.588 |
0.769 |
| CYP2D7 |
A0A087X1C5
|
cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene)
|
|
|
0.659 |
0.577 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| CYTB |
P00156
|
cytochrome b
|
|
|
0.529 |
0.808 |
| ND1 |
P03886
|
NADH dehydrogenase, subunit 1 (complex I)
|
Enzyme
|
|
0.522 |
0.769 |
| NEFL |
P07196
|
neurofilament light
|
|
|
0.488 |
0.769 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
| ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
| UGT1A |
|
UDP glucuronosyltransferase family 1 member A complex locus
|
|
|
0.540 |
0.654 |
| GHS |
|
Goldenhar syndrome
|
|
|
0.659 |
0.615 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| NANS |
Q9NR45
|
N-acetylneuraminate synthase
|
Enzyme
|
|
0.545 |
0.692 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| LPAL2 |
Q16609
|
lipoprotein(a) like 2, pseudogene
|
Enzyme
|
|
0.626 |
0.731 |
| DBA2 |
|
Diamond-Blackfan anemia 2
|
|
|
0.599 |
0.731 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |